NDC properties for NDC 9 55513-399
NDC item 55513039901
| NDC 9 | 55513-399 |
|---|---|
| NDC 10 | 55513-399-01 |
| NDC Item | 55513039901 |
| packaging | 1 SYRINGE in 1 CARTON (55513-399-01) / .2 mL in 1 SYRINGE |
| BLA | BLA761024 |
| Labeler | Amgen, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
NDC item 72511039901
| NDC 9 | 72511-399 |
|---|---|
| NDC 10 | 72511-399-01 |
| NDC Item | 72511039901 |
| packaging | 1 SYRINGE in 1 CARTON (72511-399-01) / .2 mL in 1 SYRINGE |
| BLA | BLA761024 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-11-08 |
| Marketing status | ACTIVE |
NDC item 84612039901
| NDC 9 | 84612-399 |
|---|---|
| NDC 10 | 84612-399-01 |
| NDC Item | 84612039901 |
| packaging | 1 SYRINGE in 1 CARTON (84612-399-01) / .2 mL in 1 SYRINGE |
| BLA | BLA761024 |
| Labeler | Nuvaila Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |